Enable rapid NHS expansion by simplifying clinical safety and governance work for organisations adopting your product.
Many companies find scaling slows when NHS customers must complete safety and governance work before adopting their product. DCB0160 is often where providers get stuck, and addressing it can unlock growth and differentiate your product. This is most relevant to:
Structured compliance support for your customers to deploy your product safely, efficiently, and at scale.
For the rollout of your digital health technology, we will typically provide:
We work across healthtech and care delivery, so understand both how products are built and how they are actually used, and what your customers need from you.
We’ve built healthtech products ourselves, so know how to use compliance as an enabler and accelerator, not a blocker.
We care about the future of digital health, and bring energy and creativity to solving problems, not slowing you down.
We co-author peer-reviewed research assessing NHS digital health technologies
We right-size compliance: pragmatic, proportionate, and defensible - prioritising real risk over paperwork and performative controls.
We help you meet regulatory and compliance expectations with confidence, producing work that stands up to scrutiny from partners, buyers, and regulators.
Book a call to discuss how we can accelarate your sales and real-world implementation, in 20 minutes
This depends on your commercial model. Some companies include this as part of their offering, while others share or pass on the cost to customers. We can support whichever approach works best.
Providers can complete DCB0160 on their own, and some do. However, the process requires specific clinical safety expertise and technical understanding, which many organisations do not have in-house, particularly because DCB0160 enforcement has historically been inconsistent. With new AI tools and technologies being deployed, NHS guidance (e.g. the June 2025 letter on ambient scribes) now expects providers to ensure robust clinical safety assessments. Many organisations therefore choose to work with specialists to make sure the process is thorough, efficient, and defensible.
They can. However, when this is arranged centrally through the supplier, it is typically more efficient and cost-effective, as the core work is standardised and reused across organisations. DCB0160 is also often an unforeseen cost for suppliers, as enforcement has historically been low, but this is changing. Helping customers address this pain upfront can differentiate you from competitors and help you scale faster.
Yes. In England, DCB0160 is required under the Health and Social Care Act 2012 and the NHS Standard Contract. Enforcement has historically been inconsistent, but scrutiny is increasing, particularly through CQC inspections, and following DCB0160 is considered best practice across the UK.
© Curistica Ltd. All Rights Reserved.
